IQVIA is a worldwide leader in providing analytics, technology-driven solutions, and clinical research services tailored for the life sciences industry. It was established through the merger of IMS Health and Quintiles, uniting extensive healthcare data, modern technologies, and deep analytical capabilities to support clients in driving innovation and enhancing patient health outcomes.
With a presence in over 100 countries, IQVIA partners with pharmaceutical, biotech, and healthcare organizations across all stages of the drug development process—from conducting clinical trials and collecting real-world evidence to supporting market access strategies, engaging with patients, and executing commercial operations.
Renowned for its Human Data Science approach, IQVIA blends human expertise with data science to reveal new possibilities in medical research and care. By utilizing one of the largest and most comprehensive healthcare data resources globally, along with AI-powered insights, IQVIA empowers smarter, faster decisions in medicine development.
Driven by a mission to improve patient outcomes, advance innovation, and deliver impactful healthcare solutions, IQVIA continues to redefine how healthcare services are developed and delivered around the globe.
